Sergio Cifuentes: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X:
“Intravenous Mg and Cisplatin-Associated Acute Kidney Injury.
Intravenous magnesium (IV Mg) should be prioritized in:
-
Women under 65 years old with an eGFR ≥90 and baseline serum magnesium levels of 2.0–2.2 mg/dL.
-
Patients receiving low doses of cisplatin (<50 mg).
-
Patients with diabetes.”
Title: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
Authors: Shruti Gupta, Ilya G. Glezerman, Jamie S. Hirsch, Api Chewcharat, Sophia L. Wells, Jessica L. Ortega, Marta Pirovano, Raphael Kim, Kevin L. Chen, Kenar D. Jhaveri, Valda D. Page, Matthew H. Abramson, Anip Bansal, Avisek Ghimire, Melanie S. Joy, Ala Abudayyeh, David E. Leaf
Read The Full Article at JAMA Network.
Read more posts featuring Sergio Cifuentes.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023